News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lilly ICOS LLC (LLY) Release: Cialis Filed In European Union For Once-A-Day Dosing For Erectile Dysfunction



6/8/2006 2:51:12 PM

BOTHELL, Wash.--(BUSINESS WIRE)--June 7, 2006--ICOS Corporation (Nasdaq:ICOS - News) today announced that Lilly ICOS LLC, its joint venture with Eli Lilly and Company (NYSE:LLY - News), has submitted a regulatory filing for marketing approval to the European Medicines Agency (EMEA) for CialisĀ® (tadalafil) 2.5 mg and 5 mg once-a-day dosing to treat erectile dysfunction (ED). Lilly ICOS plans to file in the United States and Canada later in 2006. If approved, the first launches could occur in late 2007.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES